Advocates Tout Drug Patent Bills As Pay-For Amid Health Reform, Approps Uncertainty

By Gabrielle Wanneh / February 21, 2024 at 6:40 PM
Health care advocates say bipartisan prescription drug patent reforms could emerge as a pay-for for other pressing health care priorities if Congress is able to cobble together a health extender package by this spring, particularly since hospital site-neutral offsets appear to be falling by the wayside, or could be sidelined for consideration later in the year along with pharmacy benefit manager and other health reforms. A strong interest remains among lawmakers to include legislation that would reform the patent system...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.